| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | XN4TL6M50Z |
| InChI Key | RFQHCLMGLJGZNV-UXXOMSPDSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C28H42O4S |
| Molecular Weight | 474.71 |
| AlogP | 5.8 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 74.6 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 33.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Vitamin D receptor agonist | Other |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 24
Cytochrome P450 family 24A
Cytochrome P450 24A1
|
- | 27 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Psoriasis | 2 | D011565 | ClinicalTrials |
| Renal Insufficiency, Chronic | 2 | D051436 | ClinicalTrials |
| Hyperparathyroidism, Secondary | 2 | D006962 | ClinicalTrials |
| Kidney Failure, Chronic | 2 | D007676 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2105705 |
| FDA SRS | XN4TL6M50Z |
| PubChem | 10672195 |